The Latest Breaking News from Quiver

This Surging Small-Cap Biotech Has One Very High-Profile Investor

Humacyte is a pre-revenue biotech company that has delivered outsized gains to shareholders in 2024. But is the small-cap stock a good buy right now?

Barchart · Jun 3, 2024

Quiver Quantitative Closes $2M Round Led By Allos Ventures

Quiver Quantitative, an alternative data platform for retail investors, formally announced the closure of a $2 million round led by Allos Ventures.

Benzinga · Mar 3, 2022